Winning on all fronts
The killing of bacteria means endotoxins are released from dead cells and cell debris is left in the wound. But unlike antimicrobial dressings that actively kill bacteria, Sorbact removes bacteria, irreversibly binding them to its surface to reduce bioburden and support wound healing. Sorbact has no contraindications and low risk of allergies. It can even be used with newborns[1]View reference information, pregnant and lactating women.*
*Note precautions for Sorbact Gel Dressing in IFU
Sorbact reduces the bioburden in wounds
Based on natural processes and physical interactions, Sorbact removes bacteria to prevent and treat infection without releasing active agents into the wound.
Effective wound healing
Safe and effective removal of bacteria reduces the bioburden in wounds which facilitates the healing process. It is also shown that Sorbact exhibits high cell compatibility and does not change cell morphology.
Respond to the rise of antimicrobial resistance with Sorbact
The whole world has woken up to the challenge of antimicrobial resistance (AMR). Without effective tools for prevention and adequate treatment of infections, the number of people for whom treatment is failing will increase. Antimicrobial Stewardship (AMS) initiatives offer an opportunity to reduce the rate of AMR and Sorbact dressings can form a valuable part of your AMS strategy.
References
-
Data on file. ABIGO Medical.
Back